Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $228K 1,105 sh | Jul 7, 2026 traded Jul 6, 2026 | |
Perry Jennifer ScottChief Operating Officer |
Open-market sale · 10b5-1 plan |
| SELL |
| $1,445 333 sh |
| Jul 7, 2026 traded Jul 6, 2026 |
| 16 | Muken RossDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $51K 9,838 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 16 | Camblong JurgiDirector, Executive Chairman | Open-market sale · 10b5-1 plan | SELL | $118K 22.5K sh | Jul 7, 2026 traded Jul 6, 2026 |
| 16 | April McClain DelaneyDDependent child | Partial sale | SELL | $1,001 – $15K | Jul 7, 2026 traded Jun 10, 2026 |
| 15 | Hettrich KevinCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $71K 9,800 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 15 | Schlossman RobertChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $18K 122 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 14 | Potts James REVP Gen Counsel & Secretary | Open-market sale · 10b5-1 plan | SELL | $68K 1,802 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 14 | Tabak ShawnCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $403K 25.0K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 13 | April McClain DelaneyDDependent child | Partial sale | SELL | $1,001 – $15K | Jul 7, 2026 traded Jun 12, 2026 |
| 13 | Pieper StevenSee Remarks | Open-market sale · 10b5-1 plan | SELL | $148K 17.4K sh | Jul 7, 2026 traded Jul 6, 2026 |
| 13 | Cardoza GeorgeChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $8,419 1,592 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 13 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $21K 4,241 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $15K 80 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $16K 80 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $7,839 40 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 13 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $38K 7,393 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $38K 7,393 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 13 | April McClain DelaneyDDependent child | Partial sale | SELL | $1,001 – $15K | Jul 7, 2026 traded Jun 15, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $15K 80 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $8,370 40 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 12 | Azar Samak LChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $26K 335 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 12 | Knopp Kevin J.Director, President and CEO | Open-market sale · 10b5-1 plan | SELL | $2,014 222 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 11 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $170K 686 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 11 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $232K 940 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 11 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $140K 562 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 10 | Collier CharlesPresident, Roku Media | Open-market sale · 10b5-1 plan | SELL | $175K 1,226 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 10 | Collier CharlesPresident, Roku Media | Open-market sale · 10b5-1 plan | SELL | $175K 1,226 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 10 | Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $235K 2,470 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 9 | Pieper StevenSee Remarks | Open-market sale · 10b5-1 plan | SELL | $235K 27.6K sh | Jul 7, 2026 traded Jul 7, 2026 |
| 9 | Brown Christopher D.Director | Open-market sale · 10b5-1 plan | SELL | $20K 2,200 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 9 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $277K 2,021 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $34K 138 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Potts James REVP Gen Counsel & Secretary | Open-market sale · 10b5-1 plan | SELL | $131K 3,487 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $3,002 12 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $45K 182 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Ditillo DavidChief Information Officer | Open-market sale · 10b5-1 plan | SELL | $128K 4,250 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Potts James REVP Gen Counsel & Secretary | Open-market sale · 10b5-1 plan | SELL | $133K 3,490 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 7 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $374K 25.1K sh | Jul 7, 2026 traded Jul 7, 2026 |
| 6 | Eltoukhy AdamSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $135K 3,653 sh | Jul 7, 2026 traded Jul 6, 2026 |